A detailed history of Aqr Capital Management LLC transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 15,692 shares of BDTX stock, worth $34,365. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,692
Holding current value
$34,365
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.2 - $6.58 $65,906 - $103,253
15,692 New
15,692 $68,000
Q2 2022

Aug 15, 2022

BUY
$1.5 - $3.63 $7,159 - $17,325
4,773 Added 34.36%
18,663 $46,000
Q1 2022

May 16, 2022

BUY
$2.66 - $5.61 $36,947 - $77,922
13,890 New
13,890 $38,000

Others Institutions Holding BDTX

About Black Diamond Therapeutics, Inc.


  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $79.6M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.